Results 201 to 210 of about 61,679 (338)

TREATMENT OF ACTIVE STAGES OF RETINOPATHY OF PREMATURE BABIES WITH THE USE OF MODERN TECHNOLOGIES

Офтальмохирургия, 2015
Purpose. To show the basic regulations of the complex retinopathy of prematurity (ROP) treatment with use of retinal pattern scanning laser coagulation and early vitrectomy. Material and methods.
A. V. Tereshchenko, Yu. A. Belyy, I. G. Trifanenkova, M. S. Tereshchenkova   +3 more
doaj  

Retinopathy of prematurity: a review of risk factors and their clinical significance.

Survey of ophthalmology, 2018
S. Kim, Alexander D. Port, Ryan Swan, J. Campbell, R. P. Chan, M. Chiang   +5 more
semanticscholar   +1 more source

Absence of Evidence of Beneficial Effects of Human Milk‐Based Fortifier: A Bayesian Model‐Averaged Meta‐Analysis

Acta Paediatrica, Volume 114, Issue 12, Page 3309-3316, December 2025.
ABSTRACT Aim Human milk‐based fortifiers (HMBFs) have been adopted in neonatal care despite limited efficacy data. Our objective was to conduct a Bayesian re‐analysis of the current evidence on the protective effect of HMBF against necrotising enterocolitis (NEC, stage II‐III).
Maurice J. Huizing, Giulia Vizzari, František Bartoš, Giacomo Cavallaro, Maria L. Gianni, Eduardo Villamor   +5 more
wiley   +1 more source

Treatment of active stages of retinopathy of premature babies with the use of modern technologies

Офтальмохирургия, 2013
Purpose. To show the basic regulations of the complex retinopathy of prematurity (ROP) treatment with use of retinal pattern scanning laser coagulation and early vitrectomy. Material and methods.
A.V. Tereshchenko, Yu.A. Belyy, I.G. Trifanenkova,, M.S. Tereshchenkova   +3 more
doaj  

Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study

Journal of Internal Medicine, Volume 298, Issue 6, Page 604-616, December 2025.
Abstract Background Type 2 diabetes mellitus (T2DM) and gout are associated with an increased risk of cardiovascular events. Despite the approval for the secondary prevention of cardiovascular diseases by the United States Food and Drug Administration in 2023, evidence regarding the effectiveness of colchicine among T2DM population remains limited ...
Minjeong Jeon, Yongtai Cho, Sungho Bea, Wonkyoung You, Sung Kweon Cho, Seungho Ryu, Yoosoo Chang, Ju‐Young Shin   +7 more
wiley   +1 more source

Artificial intelligence-based algorithms for the diagnosis of retinopathy of prematurity. [PDF]

Cochrane Database Syst Rev
Chong P, Young BK, McNamara S, Ng SM, Liu SH, Li T, Campbell JP, Kalpathy-Cramer J, Singh P.   +8 more
europepmc   +1 more source

Erythropoietin is not a risk factor for severe retinopathy of prematurity among high risk preterm infants

, 2021
Kim Chi Bui, Naomi Ellenhorn, Afshan Abbasi, Maria Fe Villosis, Marielle Nguyen, Huy Truong, Tameka Watson, Joanna Buchanan, qiaoling Chen   +8 more
openalex   +1 more source

Cost of Metabolic Dysfunction‐Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries

Liver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‐associated steatohepatitis (MASH), are highly prevalent among people living with type 2 diabetes, with estimated rates of 65.4% and 31.6%, respectively, globally.
Jeffrey V. Lazarus, Leire Agirre‐Garrido, J. Emilio Miralles‐Sanchez, Melina I. Manolas, Frank Tacke, Cristiane A. Villela‐Nogueira, Hussain Abdulrahman Al‐Omar, Saleh A. Alqahtani, Lamya Mohammed Yahya Alzubaidi, Meena Bansal, Kenneth Cusi, Scott D. Isaacs, Didac Mauricio, Teruki Miyake, Rodrigo O. Moreira, Shoko Nakazawa, Silvana Pannain, Juan M. Pericàs, Michael Roden, Hirokazu Takahashi, Nicolai Brachowicz   +20 more
wiley   +1 more source

Caregiver Impact and Understanding of Retinopathy of Prematurity Screening. [PDF]

J Patient Exp
Song W, Hui M, Khitri M, Chu A, Tsui I.
europepmc   +1 more source